New Key Statistics Module, Z-Score and F-Score
NAS:VTGN Key Ratios
| Market Cap $ M | 120.26 |
| Enterprise Value $ M | 1.63 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.98 |
| Price/Sales | 50.72 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1.00 |
| EPS (TTM) $ | -3.51 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | 33.50 |
| 5-y EBITDA Growth Rate % | 27.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.05 |
| EV-to-EBITDA | -0.05 |
| PEG | -- |
| Shares Outstanding M | 27.03 |
| Net Margin (%) | -3,074.59 |
| Operating Margin % | -3,250.43 |
| Pre-tax Margin (%) | -3,074.40 |
| Quick Ratio | 30.76 |
| Current Ratio | 30.76 |
| ROA % (ttm) | -67.06 |
| ROE % (ttm) | -80.76 |
| ROIC % (ttm) | -653.40 |
| Dividend Yield % | -- |
| Altman Z-Score | 6.34 |
VTGN Number of Guru Trades
VTGN Volume of Guru Trades
Gurus Latest Trades with NAS:VTGN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:VTGN is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Vistagen Therapeutics Inc Insider Transactions
No Available Data
News about NAS:VTGN
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers